We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
521 hedge funds and large institutions have $30B invested in Alexion Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 193 increasing their positions, 196 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more funds holding in top 10
Funds holding in top 10: 9 → 15 (+6)
45% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 42
3% more funds holding
Funds holding: 504 → 521 (+17)
3% more capital invested
Capital invested by funds: $29B → $30B (+$978M)
2% less repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 196
33% less call options, than puts
Call options by funds: $116M | Put options by funds: $172M
Holders
521
Holders Change
+17
Holders Change %
+3.37%
% of All Funds
14.98%
Holding in Top 10
15
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+66.67%
% of All Funds
0.43%
New
61
Increased
193
Reduced
196
Closed
42
Calls
$116M
Puts
$172M
Net Calls
-$56M
Net Calls Change
-$50.1M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$469M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$126M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$112M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$79.6M |
| 5 |
Two Sigma Investments
New York
|
-$76.6M |
